Earnings - 5 quarters in a row positive earnings. From losing for many years - turnaround. Earnings up 400% last quarter - announced last week. Rationalizing costs and restructuring/integration of acquisitions. Improving both gross and net margins.
Balance Sheet - Pristine balance sheet - NO DEBT Hidden assets of $35M NOL plus owned RE on Miami Ave worth IMO $1 - $2 per share. Adding cash with net earnings.
Mgmt - New seasoned management CEO, head of Sales... Mgmt has long term successful track record - earnings, high growth and acquisitions. New chairman invests his own money buying 82% of the common stock. Aligned management interests with shareholders.
Growth - Grew sales/revenues 46% or better year over year. 2 Acquisitions and successful integration - Diabetes. ERB guidance for many more acquisitions to come. 10 ERB companies not yet acquired. 95 countries. Hundreds of millions in sales. Already working together. New markets opened. New offices in Mexico. Hinted on CC about Brazil. Doubling of manufacturing capacity in Miami Lakes. R&D - new products announced. Some waiting for FDA and or CE approval. New innovative products - 200 FDA approvals and 400 CE approved products.
Market Data 
Markets 
AI
